Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (41)
Mehmet Fatih Ceylan, Selma Tural Hesapcioglu, Seda Kanoğlu Yüksekkaya, Görkem Erçin, Cansu Pınar Yavas, Salim Neşelіoğlu & Ozcan Erel. (2023) Changes in neurofilament light chain protein (NEFL) in children and adolescents with Schizophrenia and Bipolar Disorder: Early period neurodegeneration. Journal of Psychiatric Research 161, pages 342-347.
Crossref
Crossref
Sahar Foshati, Maryam Poursadeghfard, Zahra Heidari & Reza Amani. (2023)
The effect of ginger (
Zingiber officinale
) supplementation on clinical, biochemical, and anthropometric parameters in patients with multiple sclerosis: a double-blind randomized controlled trial
. Food & Function 14:8, pages 3701-3711.
Crossref
Crossref
Monokesh K. Sen, Md Jakir Hossain, David A. Mahns & Bruce J. Brew. (2022) Validity of serum neurofilament light chain as a prognostic biomarker of disease activity in multiple sclerosis. Journal of Neurology 270:4, pages 1908-1930.
Crossref
Crossref
Damiano Paolicelli, Maddalena Ruggieri, Alessia Manni, Concetta D. Gargano, Graziana Carleo, Claudia Palazzo, Antonio Iaffaldano, Luca Bollo, Tommaso Guerra, Annalisa Saracino, Antonio Frigeri, Pietro Iaffaldano & Maria Trojano. (2022) Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients. Brain Sciences 12:12, pages 1595.
Crossref
Crossref
Axel Petzold. (2022) The 2022 Lady Estelle Wolfson lectureship on neurofilaments. Journal of Neurochemistry 163:3, pages 179-219.
Crossref
Crossref
Liangxia Ning & Bin Wang. (2022) Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: A systematic review and meta-analysis. PLOS ONE 17:9, pages e0274565.
Crossref
Crossref
Ingeborg E. van Zeggeren, Liora ter Horst, Hans Heijst, Charlotte E. Teunissen, Diederik van de Beek & Matthijs C. Brouwer. (2022) Neurofilament light chain in central nervous system infections: a prospective study of diagnostic accuracy. Scientific Reports 12:1.
Crossref
Crossref
Athina-Maria Aloizou, Ioannis Liampas, Antonios Provatas, Alexandros Brotis, Vasileios Siokas, Christos Bakirtzis, Panagiotis Liakos, Zisis Tsouris & Efthimios Dardiotis. (2022) Baseline neurofilament levels in cerebrospinal fluid do not correlate with long-term prognosis in multiple sclerosis. Multiple Sclerosis and Related Disorders 64, pages 103940.
Crossref
Crossref
Rodolfo A. Kölliker Frers, Matilde Otero-Losada, Tamara Kobiec, Lucas D. Udovin, María Laura Aon Bertolino, María I. Herrera & Francisco Capani. (2022) Multidimensional overview of neurofilament light chain contribution to comprehensively understanding multiple sclerosis. Frontiers in Immunology 13.
Crossref
Crossref
Samuel S. ShinMarco M. HeftiVanessa M. MazandiDavid A. IssadoreDavid F. MeaneyAndrea L. C. SchneiderRamon Diaz-ArrastiaTodd J. Kilbaugh. (2022) Plasma Neurofilament Light and Glial Fibrillary Acidic Protein Levels over Thirty Days in a Porcine Model of Traumatic Brain Injury. Journal of Neurotrauma 39:13-14, pages 935-943.
Crossref
Crossref
Patrizia LoPresti. (2022) Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis. Biomedicines 10:5, pages 1077.
Crossref
Crossref
G. M. Oremek, K. Passek, M. Braun, J. Droege & D. Ohlendorf. (2022) Neurofilament-Leichtketten (NFL) als prognostischer Biomarker in der Diagnostik der multiplen SkleroseNeurofilament light chains (NFL) as prognostic biomarker in the diagnostics of multiple sclerosis. Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie 72:3, pages 129-132.
Crossref
Crossref
Massimiliano Mirabella, Pietro Annovazzi, Wallace Brownlee, Jeffrey A. Cohen, Christoph Kleinschnitz & Christian Wolf. (2022) Treatment Challenges in Multiple Sclerosis – A Continued Role for Glatiramer Acetate?. Frontiers in Neurology 13.
Crossref
Crossref
Gabriel Pardo, Samantha Coates & Darin T. Okuda. (2021) Outcome measures assisting treatment optimization in multiple sclerosis. Journal of Neurology 269:3, pages 1282-1297.
Crossref
Crossref
Johanna Gutiérrez‑Vargas, John Castro‑Álvarez, Jose Zapata‑Berruecos, Komal Abdul‑Rahim & Anibal Arteaga‑Noriega. (2022) Neurodegeneration and convergent factors contributing to the deterioration of the cytoskeleton in Alzheimer's disease, cerebral ischemia and multiple sclerosis (Review). Biomedical Reports 16:4.
Crossref
Crossref
Spyros Papapetropoulos, Angela Pontius, Elizabeth Finger, Virginija Karrenbauer, David S. Lynch, Matthew Brennan, Samantha Zappia, Wolfgang Koehler, Ludger Schoels, Stefanie N. Hayer, Takuya Konno, Takeshi Ikeuchi, Troy Lund, Jennifer Orthmann-Murphy, Florian Eichler & Zbigniew K. Wszolek. (2022) Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: Review of Clinical Manifestations as Foundations for Therapeutic Development. Frontiers in Neurology 12.
Crossref
Crossref
Valentina Ignatova. 2022. Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments [Working Title]. Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments [Working Title].
Giuseppina Tesco & Selene Lomoio. (2022) Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?. Seminars in Immunology 59, pages 101628.
Crossref
Crossref
Annie Killoran. 2022. Neurodegenerative Diseases Biomarkers. Neurodegenerative Diseases Biomarkers
235
262
.
Jakob Morgenstern, Jan B. Groener, Johann M. E. Jende, Felix T. Kurz, Alexander Strom, Jens Göpfert, Zoltan Kender, Maxime Le Marois, Maik Brune, Rohini Kuner, Stephan Herzig, Michael Roden, Dan Ziegler, Martin Bendszus, Julia Szendroedi, Peter Nawroth, Stefan Kopf & Thomas Fleming. (2021) Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy. Diabetologia 64:12, pages 2843-2855.
Crossref
Crossref
Sarah Harris, Giancarlo Comi, Bruce A. C. Cree, Douglas L. Arnold, Lawrence Steinman, James K. Sheffield, Harry Southworth, Ludwig Kappos & Jeffrey A. Cohen. (2021) Plasma neurofilament light chain concentrations as a biomarker of clinical and radiologic outcomes in relapsing multiple sclerosis: Post hoc analysis of Phase 3 ozanimod trials. European Journal of Neurology 28:11, pages 3722-3730.
Crossref
Crossref
Sara Momtazmanesh, Parnian Shobeiri, Amene Saghazadeh, Charlotte E. Teunissen, Joachim Burman, Levente Szalardy, Peter Klivenyi, Ales Bartos, Adelaide Fernandes & Nima Rezaei. (2021) Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis. Reviews in the Neurosciences 32:6, pages 573-595.
Crossref
Crossref
Taesik Yun, Yoonhoi Koo, Yeon Chae, Dohee Lee, Hakhyun Kim, Soochong Kim, Dongwoo Chang, Ki‐Jeong Na, Mhan‐Pyo Yang & Byeong‐Teck Kang. (2021) Neurofilament light chain as a biomarker of meningoencephalitis of unknown etiology in dogs. Journal of Veterinary Internal Medicine 35:4, pages 1865-1872.
Crossref
Crossref
Alexey Boyko, Christina Therapontos, Dana Horakova, Jarmila Szilasiová, Jolanta Kalniņa, Julia Kolontareva, Katrin Gross-Paju, Krzysztof Selmaj, Ieva Sereike, Ron Milo, Tereza Gabelić & Uroš Rot. (2021) Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals. Multiple Sclerosis and Related Disorders 50, pages 102778.
Crossref
Crossref
Hernan Inojosa, Undine Proschmann, Katja Akgün & Tjalf Ziemssen. (2019) A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition. Journal of Neurology 268:4, pages 1210-1221.
Crossref
Crossref
Hernan Inojosa, Undine Proschmann, Katja Akgün & Tjalf Ziemssen. (2021) Should We Use Clinical Tools to Identify Disease Progression?. Frontiers in Neurology 11.
Crossref
Crossref
Terry R. Suk & Maxime W. C. Rousseaux. (2020) The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Molecular Neurodegeneration 15:1.
Crossref
Crossref
Seyed-Mahdi Khaligh-Razavi, Maryam Sadeghi, Mahdiyeh Khanbagi, Chris Kalafatis & Seyed Massood Nabavi. (2020) A self-administered, artificial intelligence (AI) platform for cognitive assessment in multiple sclerosis (MS). BMC Neurology 20:1.
Crossref
Crossref
André Huss, Markus Otto, Makbule Senel, Albert C. Ludolph, Ahmed Abdelhak & Hayrettin Tumani. (2020) A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course. Frontiers in Neurology 11.
Crossref
Crossref
Magdalena Oset, Mariusz Stasiolek & Mariola Matysiak. (2020) Cognitive Dysfunction in the Early Stages of Multiple Sclerosis—How Much and How Important?. Current Neurology and Neuroscience Reports 20:7.
Crossref
Crossref
E. D. Shedko & M. A. Tyumentseva. (2020) Molecular Biomarkers in the Cerebrospinal Fluid in Multiple Sclerosis. Neuroscience and Behavioral Physiology 50:5, pages 527-533.
Crossref
Crossref
Jae-Won Hyun, Yeseul Kim, Gayoung Kim, Su-Hyun Kim & Ho Jin Kim. (2019) Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis. Multiple Sclerosis Journal 26:6, pages 659-667.
Crossref
Crossref
Kate L. Lambertsen, Catarina B. Soares, David Gaist & Helle H. Nielsen. (2020) Neurofilaments: The C-Reactive Protein of Neurology. Brain Sciences 10:1, pages 56.
Crossref
Crossref
HongZhou Wang, WanHua Wang, HaiCun Shi, LiJian Han & PingLei Pan. (2020) Cerebrospinal fluid and blood levels of neurofilament light chain in Parkinson disease. Medicine 99:31, pages e21458.
Crossref
Crossref
Zahra Alirezaei, Mohammad Hossein Pourhanifeh, Sarina Borran, Majid Nejati, Hamed Mirzaei & Michael R. Hamblin. (2019) Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders. Molecular Neurobiology 57:1, pages 469-491.
Crossref
Crossref
Kristen A. McLaurin, Rosemarie M. Booze & Charles F. Mactutus. (2019) Diagnostic and prognostic biomarkers for HAND. Journal of NeuroVirology 25:5, pages 686-701.
Crossref
Crossref
Renan Barros DOMINGUES, Gustavo Bruniera Peres FERNANDES, Fernando Brunale Vilela de Moura LEITE & Carlos SENNE. (2019) Neurofilament light chain in the assessment of patients with multiple sclerosis. Arquivos de Neuro-Psiquiatria 77:6, pages 436-441.
Crossref
Crossref
Florian Deisenhammer, Henrik Zetterberg, Brit Fitzner & Uwe K. Zettl. (2019) The Cerebrospinal Fluid in Multiple Sclerosis. Frontiers in Immunology 10.
Crossref
Crossref
Kristin N. Varhaug, Øivind Torkildsen, Kjell-Morten Myhr & Christian A. Vedeler. (2019) Neurofilament Light Chain as a Biomarker in Multiple Sclerosis. Frontiers in Neurology 10.
Crossref
Crossref
V. M. Alifirova, E. M. Kamenskikh & E. S. Koroleva. (2019) Evaluation of serum neurofilament light chains levels for diagnosis, treatment monitoring and prognosis in multiple sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:10, pages 7.
Crossref
Crossref
E. D. Shedko & M. A. Tyumentseva. (2019) Cerebrospinal fluid molecular biomarkers of multiple sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:7, pages 95.
Crossref
Crossref